1Murase J, Gilliam AC. Disseminated superficial actinic porokeratosis co - existing with linear and verrucous poro- keratosis in an elderly woman: Update on the genetics and clinical expression of porokeratosis [ J ]. J Am Acad Dermatol, 2010, 63(5): 886-891.
2Skroza N, Proietti I, Bernardini N, et al. Acitretin for treatment of familial porokeratosis palmaris et plantaris disseminate[ J]. Eur J Dermatol, 2012, 22 (5): 699- 700.
8Gutierrez PE, Bella NR, Montesinos VE,et al. Porokera- tosis of Mibelli : a new indication for photodynamic thera- py? [ J]. Actas Dermosifiliogr, 2013, 104 (3) :259 - 261.
9Curkova AK, Hegyi J, Kozub P,et al. A ease of linear porokeratosis treated with photodynamic therapy with con- focal microscopy surveillance[ J]. Dermatol Ther, 2013, doi : 101111/dth. 12097.
2Niimi Y, Kawana S. Type 2 segmental manifestation of disseminated superficial actinic porokeratosis in a 7 - year -old girl[J]. Eur J Dermatol, 2009, 19( 1 ) :25 -28.
2Chen TJ, Chou YC, Chen CH, et al. Genital porokerato- sis: a series of 10 patients and review of the literature [J]. Br J Dermatol, 2006, 155(2) : 325-329.
3Zhang ZH, Huang W, Niu ZM, et al. Two closely linked variations in actin cytoskeleton pathway in a Chinese ped- igree with disseminated superficial actinic porokeratosis [ J]. J Am Acad Dermatol, 2005, 52(6):972-976.
4Herranz P, Pizarro A, De Lucas R, et al. High inci- dence of porokeratosis in renal transplant recipients [ J ]. Br J Dermatol, 1997, 136(2): 176-179.
5Gu CY, Zhang CF, Chen LJ, et al. Clinical analysis and etiology of porokeratosis [ J]. Exp Ther Med, 2014, 8 (3) :737-741.
6Jung JY, Yeon JH, Ryu HS, et al. Disseminated super- ficial porokeratosis developed by immunosuppression due to rheumatoid arthritis treatment [ J ]. J Dermatol, 2009, 36(8) : 466-467.
7Ferreira FR, Santos LD, Tagliarini FA, et al. Porokera- tosis of Mibelli-literature review and a case report [ J ]. An Bras Dermatol, 2013, 88(6 Suppl 1 ) :179-182.